Sparrow Pharmaceuticals
Sparrow Pharmaceuticals is a clinical-stage biopharmaceutical company addressing metabolic dysfunction from excess cortisol. Leveraging underappreciated scientific insights into corticosteroid biology, the company is working to deliver improved outcomes for patients who struggle to control diabetes and related metabolic conditions with current options. Its lead product, clofutriben, is an oral, small molecule, designed to target the source of active intracellular cortisol in key tissues. The company was founded in 2013 by David A. Katz and is based in Portland, Oregon, United States.
Domain
sparrowpharma.com
Country
United StatesIndustry
BiopharmaEmployees
1-10
Last Funding
$95.0M
Founded
2012
Tech Stack (10 technologies)
Frequently Asked Questions
What technologies does Sparrow Pharmaceuticals use?+
Sparrow Pharmaceuticals uses 10 technologies including Adobe Fonts, Squarespace, Squarespace Commerce.
What industry is Sparrow Pharmaceuticals in?+
Sparrow Pharmaceuticals operates in the Biopharma industry.
Where is Sparrow Pharmaceuticals based?+
Sparrow Pharmaceuticals is headquartered in United States.
Explore More
Need this data at scale?
Get ready-to-use datasets: companies, technologies, and tech adoption signals across 3M+ websites.
Browse DatasetsData last updated: June 2026